Representational image of water supply. 
Chennai

Erratic water supply irks Nesapakkam residents

With mercury levels soaring, life has been more taxing for residents of Nesapakkam over the past few weeks without a regular metro water supply in the area.

S Guruvanmikanathan

CHENNAI: With mercury levels soaring, life has been more taxing for residents of Nesapakkam over the past few weeks without a regular metro water supply in the area.

Residents of Indira Nagar have been facing
a severe water crisis for the past two weeks
due to irregular metro water supply | Martin Louis

Despite numerous complaints, nothing has been done so far, said N Elumalai, president of the Indira Nagar Welfare Association in Nesapakkam. He expressed disappointment over the lack of response from metro water and said the residents are facing immense hardships as they are forced to rely on alternative sources of water for their daily needs.

Elumalai said the issue was not with the residential sump connections, claiming the fault must be either at the starting point or in the main water line. He urged the metro water officials to rectify the fault immediately.

The residents’ association secretary N Kumar said when metro water officials inspected the area, they instructed the residents to get prior permission for road digging to check the main line underground pipelines. However, the corporation officials demanded Rs 6,000 as payment to grant permission, which came down to Rs 3,000 after negotiations.

Chennai Metro Water officials said they are inspecting the area and action would be taken to restore the water supply soon.

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’